SEI Investments
ACHV icon

SEI Investments’s Achieve Life Sciences ACHV Stock Holding History

SEI Investments’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Buy
+20,500
New +$97.8K ﹤0.01% 3137

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SEI Investments's ACHV Position: Q2 2026 in Review

SEI Investments opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 20,500 shares worth $134K. The stake represents ﹤0.01% of the portfolio and ranks #3137 among its holdings.

111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • SEI Investments held 20,500 shares of Achieve Life Sciences worth $134K as of Q2 2026.
  • Achieve Life Sciences was a new SEI Investments position in Q2 2026.
  • Achieve Life Sciences made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3137 holding.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.